Exploring Alzheimer's disease and its risk factors
Vanderbilt Alzheimer's Disease Research Center
The Vanderbilt Alzheimer's Disease Research Center is working to learn more about Alzheimer's disease by studying how different factors can increase the risk or help protect against it, and they invite patients to join in this important research to help find new treatments and ways to spot the disease early.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10876856 on NIH RePORTER |
What this research studies
The Vanderbilt Alzheimer's Disease Research Center aims to enhance understanding of Alzheimer's disease by establishing a comprehensive research infrastructure. This center will utilize advanced techniques in clinical, neuroimaging, genetic, and biospecimen data collection to identify factors that increase the risk of Alzheimer's or promote resilience against it. Patients may be involved in various aspects of the research, contributing to the development of innovative treatments and early identification methods for Alzheimer's disease and related dementias. The center builds on existing resources and aims to foster collaboration among researchers to drive forward the science of Alzheimer's.
Who could benefit from this research
Good fit: Ideal candidates for participation are older adults aged 21 and above, particularly those at risk for or diagnosed with Alzheimer's disease.
Not a fit: Patients who are younger than 21 or do not have any risk factors or diagnosis related to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for early detection and new therapeutic options for Alzheimer's disease.
How similar studies have performed: Previous research initiatives focused on Alzheimer's disease have shown promise in identifying risk factors and developing new treatments, indicating that this approach has potential for success.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Jefferson, Angela L. — Vanderbilt University Medical Center
- Study coordinator: Jefferson, Angela L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.